Franklin Resources Inc. Buys Shares of 500,000 Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Franklin Resources Inc. bought a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 500,000 shares of the company’s stock, valued at approximately $8,575,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Stephens Inc. AR purchased a new position in Guardian Pharmacy Services during the 3rd quarter valued at $189,000. Virtu Financial LLC purchased a new stake in shares of Guardian Pharmacy Services during the third quarter valued at $279,000. Barclays PLC bought a new position in shares of Guardian Pharmacy Services in the third quarter worth about $311,000. Point72 DIFC Ltd purchased a new position in Guardian Pharmacy Services in the 3rd quarter worth about $573,000. Finally, Royce & Associates LP bought a new stake in Guardian Pharmacy Services during the 3rd quarter valued at about $1,260,000.

Insider Buying and Selling at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were acquired at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the purchase, the director now owns 35,714 shares of the company’s stock, valued at approximately $499,996. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Steven D. Cosler acquired 7,000 shares of the business’s stock in a transaction dated Tuesday, November 19th. The shares were bought at an average price of $21.22 per share, for a total transaction of $148,540.00. Following the acquisition, the director now owns 17,713 shares of the company’s stock, valued at approximately $375,869.86. This represents a 65.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here.

Guardian Pharmacy Services Stock Performance

Shares of GRDN stock opened at $21.41 on Friday. The company’s 50-day moving average is $21.19. Guardian Pharmacy Services, Inc. has a 1-year low of $14.16 and a 1-year high of $25.74.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million for the quarter, compared to analyst estimates of $303.21 million. On average, equities analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

GRDN has been the topic of several research reports. Truist Financial raised their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Stephens assumed coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price target for the company. Finally, Raymond James initiated coverage on shares of Guardian Pharmacy Services in a report on Monday, October 21st. They set an “outperform” rating and a $21.00 price objective on the stock.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.